- Home
- AUPH vs BCAT Comparison
AUPH vs BCAT Comparison
Compare AUPH & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- BCAT
- Stock Information
- Founded
- AUPH 1993
- BCAT 2020
- Country
- AUPH Canada
- BCAT United States
- Employees
- AUPH N/A
- BCAT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- BCAT Finance/Investors Services
- Sector
- AUPH Health Care
- BCAT Finance
- Exchange
- AUPH Nasdaq
- BCAT Nasdaq
- Market Cap
- AUPH 1.4B
- BCAT 1.5B
- IPO Year
- AUPH 1999
- BCAT N/A
- Fundamental
- Price
- AUPH $12.83
- BCAT $14.77
- Analyst Decision
- AUPH Strong Buy
- BCAT
- Analyst Count
- AUPH 3
- BCAT 0
- Target Price
- AUPH $12.00
- BCAT N/A
- AVG Volume (30 Days)
- AUPH 1.5M
- BCAT 308.8K
- Earning Date
- AUPH 11-06-2025
- BCAT 01-01-0001
- Dividend Yield
- AUPH N/A
- BCAT 9.38%
- EPS Growth
- AUPH N/A
- BCAT N/A
- EPS
- AUPH 0.42
- BCAT 1.43
- Revenue
- AUPH $260,111,000.00
- BCAT N/A
- Revenue This Year
- AUPH $16.92
- BCAT N/A
- Revenue Next Year
- AUPH $14.43
- BCAT N/A
- P/E Ratio
- AUPH $29.12
- BCAT $11.41
- Revenue Growth
- AUPH 25.59
- BCAT N/A
- 52 Week Low
- AUPH $6.55
- BCAT $13.67
- 52 Week High
- AUPH $12.90
- BCAT $16.38
- Technical
- Relative Strength Index (RSI)
- AUPH 63.83
- BCAT 42.06
- Support Level
- AUPH $12.18
- BCAT $14.64
- Resistance Level
- AUPH $12.90
- BCAT $15.29
- Average True Range (ATR)
- AUPH 0.42
- BCAT 0.12
- MACD
- AUPH -0.06
- BCAT -0.04
- Stochastic Oscillator
- AUPH 92.89
- BCAT 20.27
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.